LEI 549300J4U55H3WP1XT59

Bayer Aktiengesellschaft

Awards tracked

82

Value

€18.73M

Countries

DE

Download sample CSV

Contract awards & public grants

Molecularly Designed Polymers for Sustainable Agriculture → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2026-07-08

€290,272

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2026-06-02

—

Advancing Europe's Next Generations on the Path to Sustainability – Expanding the Universe of Enzymatic Halogenation Chemistry → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2025-07-01

—

101191967 - GREG - TESTING, IMPROVING, AND CO-CREATING GUIDANCE AND TOOLS FOR REAL WORLD EVIDENCE GENERATION IN EUROPE AND USE FOR DECISION-MAKING IN → BAYER AKTIENGESELLSCHAFT

IMI - Innov.Health Initiative · DE · Grant · 2025-05-01

€13.3M

Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2025-04-28

—

Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT) → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2024-12-16

—

Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2024-12-12

—

Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2024-11-12

—

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2024-07-26

—

Beyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s disease → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2024-06-25

€260,539

Light-driven Catalytic Processes for the Stereoselective Functionalisation of C(sp3)-H Bonds → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2024-03-26

—

Food Safety for Africa → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2023-12-06

€99,375

INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2023-10-20

—

Explainable AI for Molecules - AiChemist → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2023-07-14

€390,809

Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2023-06-23

—

Sharing and re-using clinical trial data to maximise impact → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2023-06-20

—

101083563 - DS4HEALTH - DIGITAL SKILLS FOR HEALTHCARE TRANSFORMATION → BAYER AKTIENGESELLSCHAFT

HADEA - European Health and Digital Executive Agency · DE · Grant · 2023-01-01

€245,865

a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors of emerging arboviruses → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2022-11-04

—

Advanced biodiversity monitoring for results-based and effective agricultural policy and transformation → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2022-10-14

€16,000

Risk AssessmenT InnOvatioN for low-risk pesticides → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2022-10-06

€7,500

Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2022-07-06

€72,372

Photochemical organocatalytic atropselective processes for the sustainable synthesis of biorelevant axially chiral molecules → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2022-06-08

—

Biodiversity Digital Twin for Advanced Modelling, Simulation and Prediction Capabilities → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2022-05-31

€91,875

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2021-10-18

—

FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2021-10-11

—

Building a reproducible single-cell experimental workflow to capture tumour cell persistence → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2021-06-28

—

Add medical genetic solutions to RESOLUTE (REsolution) → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2021-05-18

—

Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2021-01-29

€931,165

Central Repository for Digital Pathology → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-11-26

—

Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-11-24

—

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-11-12

—

Accelerating Research & Development for Advanced Therapies → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-11-11

—

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-11-09

—

A fully integrated, animal-free, end-to-end modelling approach to oral drug product development → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-09-07

€252,788

Advanced machine learning for Innovative Drug Discovery → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-08-24

€126,394

European Network Linking Informatics and Genomics of Helper T cells in Tissues → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-08-19

€252,788

Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-08-18

€252,788

Corona Accelerated R&D in Europe → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-08-07

—

Prioritisation and Risk Evaluation of Medicines in the EnviRonment → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-06-24

—

HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-05-26

—

EUbOPEN: Enabling and Unlocking biology in the OPEN → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2020-05-11

—

PharmaLedger → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-12-16

—

Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-09-26

—

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-08-07

—

Health.E Lighthouse Support Initiative → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-07-29

€36,888

MachinE Learning Ledger Orchestration for Drug DiscoverY → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-05-22

—

Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-04-23

—

CARdiomyopathy in type 2 DIAbetes mellitus → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-04-11

—

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-03-22

—

EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2019-02-28

—

European Screening Centre; Unique Library for Attractive Biology → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-12-18

—

FAIRplus → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-12-18

—

European Health Data and Evidence Network → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-11-22

—

A European standardization framework for data integration and data-driven in silico models for personalized medicine → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-11-13

€7,889

A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-09-13

—

Thrombo-inflammation in cardiovascular disease → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-08-20

—

The GetReal Initiative → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-06-26

—

conect4children (COllaborative Network for European Clinical Trials For Children) → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-06-22

—

Research empowerment on solute carriers (ReSOLUTE) → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-06-22

—

Ensuring the future of EUPATI beyond 2020 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-06-21

—

Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-06-21

—

Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-06-14

—

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medici → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-06-04

—

Quantitative T cell Immunology and Immunotherapy → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-05-18

€498,433

Improving the care of patients suffering from acute or chronic pain → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-05-04

—

RustWatch: A European early-warning system for wheat rust diseases → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2018-04-27

€31,254

Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical t → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2017-09-12

—

Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2017-09-12

—

Super-resolution optical microscopy of nanosized pore dynamics in endothelial cells → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2017-08-31

—

Big Data 4 Better Hearts - Sofia ref.: 116074 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2017-06-26

—

ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2017-05-18

—

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2017-03-10

—

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2017-01-30

—

Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2016-12-22

—

Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2016-12-20

—

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2016-10-21

—

Educational Network in Ocular Drug Delivery and Therapeutics → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2016-08-16

—

European Network linking informatics and genomics of helper T cells → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2015-08-07

€145,376

Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2015-07-27

€249,216

Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2015-02-18

€227,150

Integrated Control and Sensing for Sustainable Operation of Flexible Intensified Processes → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2014-11-07

€914,000

Sustainability assessment methods and tools to support decision-making in the process industries → BAYER AKTIENGESELLSCHAFT

European Commission · DE · Grant · 2014-11-05

€34,200

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.